Welcome to the Oncology Learning Network Waldenstrom Macroglobulinemia Specialty Channel. Here you will find articles dedicated to the research and treatment of WM.

The Waldenstrom's Macroglobulinemia Specialty Channel may be accessed here:


Today's news features the clinical trial conducted by Dr. Steven Treon where Ibrutinib may improve pulmonary outcomes in certain COVID-19 cases.

Findings from a small clinical trial of patients with Waldenstrom’s macroglobulinemia (WM) suggest that ibrutinib may protect against lung injury and improve pulmonary function in hypoxic patients with COVID-19 (https://doi.org/10.1182/blood.2020006288).